VELSIPITY
Identification of Velsipity
| No description |
Google image searchProduct monograph
Active ingredient
etrasimod (etrasimod l-arginine), 2 MG
DIN: 02544903
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: PFIZER CANADA ULC
Date: 18-APR-2024
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AE — Sphingosine-1-phosphate (S1P) receptor modulators (ATC, ATC/DDD)
- L04AE05 — ETRASIMOD (ATC/DDD)
